Scarica l'app Stockscreener
100.91
2.28%
2.25
Dopo l'orario di chiusura:
101.83
0.92
+0.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Is Boston Scientific (BSX) Among Billionaire Steve Cohen’s Top Stock Picks? - Insider Monkey
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Boston Scientific reaches preliminary settlement - MSN
Boston Scientific study meets goals for PFA in persistent AFib - Yahoo Finance
RBC Capital holds Boston Scientific stock Outperform rating - MSN
Top 4 Health Care Stocks You May Want To Dump In Q1 - Benzinga
Mechanics Bank Trust Department Purchases Shares of 4,646 Boston Scientific Co. (NYSE:BSX) - MarketBeat
Uterine Fibroids Treatment Devices Market Analysis and - GlobeNewswire
Uterine Fibroids Treatment Devices Market Analysis and Shares Outlook 2025-2030, Featuring Medtronic, Stryker, Boston Scientific Corp, Insightec, CooperSurgical & More - Yahoo Finance
BSX Stock Rises on Positive Data Announcement at the AF Symposium - Yahoo Finance
Boston Scientific sees success in PFA device trial - Yahoo Finance
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Avanza Fonder AB Takes $14.41 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
RBC Capital holds Boston Scientific stock Outperform rating By Investing.com - Investing.com Australia
Boston Scientific Co. (NYSE:BSX) Shares Purchased by Ritholtz Wealth Management - MarketBeat
Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
TD Cowen maintains Boston Scientific buy rating, $110 target - Investing.com
Boston Sci reports good data for Farapulse, Watchman afib systems - BioWorld Online
Boston Scientific reaches preliminary settlement By Investing.com - Investing.com Canada
Boston Scientific data supports Farapulse, Watchman FLX - Mass Device
Boston Scientific (BSX) Receives Preliminary Approval for Shareh - GuruFocus.com
Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Gateway Investment Advisers LLC Decreases Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Hennion & Walsh Asset Management Inc. Buys 7,618 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Assenagon Asset Management S.A. Has $84.77 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2,735 Shares in Boston Scientific Co. (NYSE:BSX) Bought by Claro Advisors LLC - MarketBeat
Moody National Bank Trust Division Makes New $249,000 Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific (NYSE:BSX) Reaches New 52-Week HighHere's Why - MarketBeat
Boston Scientific stock soars to all-time high of $97.13 - Investing.com
Brendel Financial Advisors LLC Purchases New Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Board of the Pension Protection Fund Invests $1.02 Million in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pines Wealth Management LLC Acquires New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Community Trust & Investment Co. - MarketBeat
Boston Scientific expects Farapulse, Watchman to drive 2025 growth - Mass Device
Boston Scientific (LTS:0HOY) 3-Year Revenue Growth Rate : 11.60% (As of Sep. 2024) - GuruFocus.com
Boston Scientific stock retains Buy rating on financial guidance - Investing.com
Brookstone Capital Management Buys 20,307 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance UK
Courier Capital LLC Has $2 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific (BSX) is Skyrocketing in 2025? - Insider Monkey
Salem Investment Counselors Inc. Has $17.58 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2 Newly Overvalued Stocks - Morningstar
Czech National Bank Boosts Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Boston Scientific Completes $1.7 Billion Offering Of Senior Notes - Reuters.com
Here’s Why Boston Scientific Corp. (BSX) Skyrocketed Today - MSN
Boston Scientific announces acquisition of the remaining stake in Bolt Medical - MSN
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement - MSN
Boston Scientific (NYSE:BSX) Raised to "Buy" at Deutsche Bank Aktiengesellschaft - MarketBeat
Deutsche Bank lifts Boston Scientific stock rating to Buy, says execution is hard - Investing.com
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth By Investing.com - Investing.com Australia
Truist maintains Boston Scientific buy rating, $110 target - Investing.com
Boston Scientific to acquire Bolt Medical - Medical Buyer
Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m - Yahoo Finance
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):